Unichem Laboratories, a Rs.790 crore plus pharma major from Mumbai, registered poor performance during the year ended March 2012 and its net profit declined by 24 per cent to Rs.82.46 crore from Rs.108.50 crore in the previous year. Its net sales also improved marginally by 4.5 per cent to Rs.793.91 crore from Rs.757.81 crore. Its earnings per share declined to Rs.9.13 from Rs.12.03 in the last period.

The company's EBDITA also moved down by 19.2 per cent to Rs.136.84 crore from Rs.169.36 crore in the previous year. The company's domestic sales declined by 7.1 per cent to Rs.556.58 crore from Rs.599.08 crore and that from international market improved smartly by 48.9 per cent to Rs.246.61 crore from Rs.165.66 crore.